Clinical trial for virgin coconut oil shows potential as supplement COVID-19 treatment
Clinical trials on virgin coconut oil (VCO) as a supplement for treatment of COVID-19 is showing promise as a majority of participants have been discharged. The initial study was conducted at Sta. Rosa Community Hospital and involved 45 patients with mild symptoms.
Department of Science and Technology (DOST) Secretary Fortunato Dela Pena says that more participants are needed to create better conclusions. A second trial with 50 participants will involve the Philippine General Hospital (PGH), and a third trial will be conducted in Singapore. Another trial involving lagundi is in the pipeline.
Editor’s Note: The beginning experimental success of VCO as a supplement for COVID-19 treatment will have massive implications. For one, it will begin to highlight the importance of nutrition and diet to health, and hopefully, prompt people to pay attention to the sources of their food. Secondly, it can begin a new round of discussions about holistic health, and hopefully, lead to revolutionize the medical field to become human and nature-friendly.
Click the button below if you wish to read the article on the website where it was originally published.
Click the button below if you wish to read the article offline.